Answer
Combining etelcalcetide hydrochloride with cinacalcet or denosumab may increase the risk of hypocalcaemia, and patients receiving etelcalcetide should not be given cinacalcet.
Sources for this answer
- ParsabivAmgen Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 7Document updated
Sources checked